Posts in category

Opinion


Response to article published in the AJP – OTC codeine death claims must stop by A/Prof Adrian Reynolds The Australian Journal of Pharmacy article with …

Peter Carroll takes a look at three recent claims around codeine Recently several claims regarding codeine have been circulating which I believe are untrue. Claim: …

Collaboration is key to being a community health destination, writes Jacqui Hagidimitriou In the age of fast-paced change in pharmacy, those who innovate will continue …

With codeine-containing medicines going to prescription-only, has the time come to again restrict the sale of all ibuprofen products to pharmacies? Ron Batagol, PhC,FSHP,AGIA, Dip.Jnl. …

Have you ever had to sell something that you didn’t quite believe? Tough isn’t it, says pharmacist Peter Feros But the scenario above is what …

NAPSA immediate past president Shefali Parekh shares her secrets to success and advice for other young women in pharmacy In the second year of my …

Direct supply is already having a negative impact on patient health, writes Paul Jaffar The issues that have been created by direct supply must be …

There are questions about some of the evidence presented to the Senate committee hearing into the effects of red tape on pharmacy rules, says Anthony Tassone   …

AJP editor Chris Brooker reflects on what the rise of the super banner group may mean to community pharmacy Crosby, Stills and Nash (and Young, …

Pharmacy is about more than just dollars and cents… it can also involve supporting people during their toughest times By Curtis Ruhnau It was on …

Medicines adherence needs a multi-pronged approach, writes Tal Rapke According to a 2003 report by the World Health Organization into medication adherence, approximately 50 per …

In Australia, some men are at increased risk of harm because they rely on access to counterfeit medicines, says Nial Wheate Nial Wheate, Senior Lecturer and BPharm …